MARLBOROUGH, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. ( AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.
- Canaccord 43rd Annual Growth Conference
Fireside Chat on Wednesday, August 9th at 9:00 AM ET
- UBS MedTech, Tools & Genomics Summit
Fireside Chat on Thursday, August 17th at 3:00 PM PT
- Morgan Stanley 21st Annual Global Healthcare Conference
Fireside Chat on Wednesday, September 13th at 10:10 AM ET
A live and archived webcast of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit http://www.akoyabio.com.
Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
[email protected]
Media Contact:
Christine Quern
(617) 650-8497
[email protected]
